Clutterbuck RD - Search Results

1

The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.

Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. Newman A, et al. Among authors: clutterbuck rd. J Investig Med. 1995 Jun;43(3):269-74. J Investig Med. 1995. PMID: 7614073

2

Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin.

Newman A, Clutterbuck RD, Powles RL, Millar JL. Newman A, et al. Among authors: clutterbuck rd. Leukemia. 1994 Nov;8(11):2023-9. Leukemia. 1994. PMID: 7967748

3

Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin.

Newman A, Clutterbuck RD, Powles RL, Millar JL. Newman A, et al. Among authors: clutterbuck rd. Leukemia. 1994 Feb;8(2):274-80. Leukemia. 1994. Corrected and republished in: Leukemia. 1994 Nov;8(11):2023-9. PMID: 8309251 Corrected and republished.

4

A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.

Newman A, Clutterbuck RD, Powles RL, Catovsky D, Millar JL. Newman A, et al. Among authors: clutterbuck rd. Leuk Lymphoma. 1997 Feb;24(5-6):533-7. doi: 10.3109/10428199709055590. Leuk Lymphoma. 1997. PMID: 9086443

5

Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice.

Clutterbuck RD, Millar BC, Powles RL, Newman A, Catovsky D, Jarman M, Millar JL. Clutterbuck RD, et al. Br J Haematol. 1998 Jul;102(2):522-7. doi: 10.1046/j.1365-2141.1998.00783.x. Br J Haematol. 1998. PMID: 9695968 Free article.

6

Growth of primary human acute leukemia in severe combined immunodeficient mice.

De Lord C, Clutterbuck R, Titley J, Ormerod M, Gordon-Smith T, Millar J, Powles R. De Lord C, et al. Exp Hematol. 1991 Oct;19(9):991-3. Exp Hematol. 1991. PMID: 1893976

7

Growth of xenografted human bone marrow: comparison with hemopoietic reconstitution in patients after allogeneic bone marrow transplant and response to granulocyte macrophage colony stimulating factor.

Clutterbuck RD, Clarke D, Powles RL, Millar JL. Clutterbuck RD, et al. Leukemia. 1989 Sep;3(9):637-42. Leukemia. 1989. PMID: 2668655

8

The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor.

Clutterbuck RD, Powles RL, Millar JL. Clutterbuck RD, et al. Br J Cancer. 1989 Jun;59(6):841-3. doi: 10.1038/bjc.1989.179. Br J Cancer. 1989. PMID: 2736221 Free PMC article. No abstract available.

9

Deletions and rearrangement of CDKN2 in lymphoid malignancy.

Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MA, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva E, et al. Stranks G, et al. Among authors: clutterbuck rd. Blood. 1995 Feb 15;85(4):893-901. Blood. 1995. PMID: 7849311 Free article.

10

Human Philadelphia chromosome-positive chronic myeloid leukemia: a potential model for antisense therapy.

De Lord C, Clutterbuck RD, Powles RL, Min T, Titley JC, Millar JL. De Lord C, et al. Among authors: clutterbuck rd. Exp Hematol. 1993 Jun;21(6):826-8. Exp Hematol. 1993. PMID: 8500581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters